Trial
NCT02762266
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
National Cancer Institute (NCI)
Condition
Child-Pugh Class A
Intervention
Stereotactic Body Radiation Therapy
Why stopped
Business decision - funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-12